Evaluating Location of Biopsy Procurement in Active Crohn*s Disease

Completed

• Conditions: Crohn's Disease; inflammatory bowel disease; 10017969

• Registration Number: NL-OMON43265
• Lead Sponsor: Robarts Clinical Trials BV

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

(1) Male or females, 18 years of age or older.
(2) Histologically confirmed Crohn*s disease (L1, L2 or L3) prior to study ileo-colonoscopy
(3) Not on systemic anticoagulation therapy including warfarin or novel oral anticoagulants
(4) Ability of subject to participate fully in all aspects of this clinical trial.
(5) Written informed consent must be obtained and documented.
(6) A single ulcer > 0.5 cm at study ileo-colonoscopy

Exclusion Criteria

Pregnant Women

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Not applicable</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable</p><br>